Levalbuterol vs racemic albuterol: science or drug company propaganda?
نویسنده
چکیده
منابع مشابه
Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma.
STUDY OBJECTIVES To compare clinical efficacy, patient outcomes, and medical costs in hospitalized patients treated with levalbuterol to those treated with racemic albuterol. DESIGN Retrospective chart review. SETTING A 180-bed community hospital. PATIENTS Patients admitted to Halifax Regional Hospital with a diagnosis code for COPD or asthma from July 1 to December 31, 1998, and from Jul...
متن کاملComparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED.
BACKGROUND Acute asthma is often treated with racemic albuterol, a 1:1 mixture of (R)-albuterol and (S)-albuterol. Levalbuterol is the single-isomer agent comprised (R)-albuterol, an active bronchodilator, without any effects of (S)-albuterol. OBJECTIVE To compare emergency department (ED) admission rates of patients presenting with acute asthma who were treated with either racemic albuterol ...
متن کاملLong-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.
BACKGROUND Previous studies have raised concerns regarding the safety of regular use of beta2-agonists for treating asthma. Few studies have explored the safety of at least 1 year of use of racemic albuterol, and none have examined long-term dosing of levalbuterol. OBJECTIVE To examine the long-term safety of levalbuterol hydrofluoroalkane (HFA) vs racemic albuterol HFA administered via meter...
متن کاملComparison of levalbuterol and racemic albuterol based on cardiac adverse effects in children.
OBJECTIVE To compare the cardiac effects of levalbuterol with those of racemic albuterol based on changes in heart rate (HR) in pediatric patients. METHODS The medical records of hospitalized children ages 1 month to 12 years, who received either levalbuterol or racemic albuterol via nebulizer for 3 consecutive doses between January 2006 and December 2008 were reviewed. The documented HR was ...
متن کاملTreatment with (R)-albuterol has no advantage over racemic albuterol.
70. Truitt T, Witko J, Halpern M. Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma. Chest 2003;123:128–135. 71. Skoner DP, Greos LS, Kim LT, Roach JM, Parsey M, Baumgartner RA. Evaluation of the safety and efficacy of levalbuterol in 2–5-year-old patients with asthma. Pediatr Pulmonol 2005;40:477–486. 72. Nelson HS, Bensch G, Pleskow...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Chest
دوره 124 3 شماره
صفحات -
تاریخ انتشار 2003